{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:12:15Z","timestamp":1779300735885,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bulcan.2026.01.009","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:48:37Z","timestamp":1772714917000},"page":"746-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study"],"prefix":"10.1016","volume":"113","author":[{"given":"Yazid","family":"Belkacemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Ceugnart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Zahra","family":"Bellefkih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Debbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.01.009_bib0095","first-page":"1568","article-title":"Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options","volume":"10","author":"Flavia Zita","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.bulcan.2026.01.009_bib0100","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042320-034052","article-title":"Precision medicine in low- and middle-income countries","volume":"17","author":"Radich","year":"2022","journal-title":"Ann Rev Pathol"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0110","doi-asserted-by":"crossref","first-page":"010803","DOI":"10.1115\/1.4045910","article-title":"Medical devices for low- and middle-income countries: a review and directions for development","volume":"14","author":"Vasan","year":"2020","journal-title":"J Med Dev"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2020.05.015","article-title":"A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries","volume":"135","author":"Belkacemi","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2026.01.009_bib0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bulcan.2020.03.008","volume":"107","author":"Gligorov","year":"2020","journal-title":"Bull Cancer"},{"issue":"5\u20136","key":"10.1016\/j.bulcan.2026.01.009_bib0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.canrad.2012.07.181","article-title":"Radioth\u00e9rapie du cancer du sein infiltrant\u00a0: recommandations nationales fran\u00e7aises [Radiotherapy of invasive breast cancer: French national guidelines]","volume":"16","author":"Besnard","year":"2012","journal-title":"Cancer Radiother"},{"issue":"6\u20137","key":"10.1016\/j.bulcan.2026.01.009_bib0130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.canrad.2023.07.006","article-title":"Limited applicability and implementation of the international oncology treatments guidelines in low- and middle-income countries, an example from the Mediterranean area borders","volume":"27","author":"Belkacemi","year":"2023","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.bulcan.2026.01.009_bib0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.bulcan.2026.01.009_bib0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.009_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2010.03.007","article-title":"Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties","volume":"78","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fpubh.2014.00087","article-title":"Delay in breast cancer: implications for stage at diagnosis and survival","volume":"2","author":"Caplan","year":"2014","journal-title":"Front Public Health"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3332\/ecancer.2019.945","article-title":"Pathology and cancer in Africa","volume":"13","author":"Fleming","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0160","doi-asserted-by":"crossref","first-page":"100408","DOI":"10.1016\/j.jpi.2024.100408","article-title":"Advancements in pathology: digital transformation, precision medicine, and beyond","volume":"16","author":"Ahuja","year":"2025","journal-title":"J Pathol Inform"},{"issue":"1","key":"10.1016\/j.bulcan.2026.01.009_bib0165","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1038\/s41598-024-62105-z","article-title":"Disparities in quality of life among patients with breast cancer based on surgical methods: a cross-sectional prospective study","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/EDBK_100028","article-title":"An arm and a leg: the rising cost of cancer drugs and impact on access","volume":"41","author":"Leighl","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0175","doi-asserted-by":"crossref","first-page":"628744","DOI":"10.3389\/fpubh.2021.628744","article-title":"Availability, affordability, access, and pricing of anti-cancer medicines in low- and middle-income countries: a systematic review of literature","volume":"9","author":"Ocran Mattila","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.bulcan.2026.01.009_bib0180","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2471\/BLT.16.185199","article-title":"End-of-life care in low- and middle-income countries","volume":"95","author":"Cruz-Oliver","year":"2017","journal-title":"Bull World Health Organ"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:58:09Z","timestamp":1779299889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0007455126001062"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.01.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}